Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Molecular and Cellular Endocrinology
|
December 6, 2003
MIS/AMH in the assessment of cryptorchidism and intersex conditions
Mary M Lee, Madhusmita Misra, Patricia K Donahoe, et al.
Molecular and Cellular Endocrinology
|
December 6, 2003
Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications
Patricia K Donahoe, Trent Clarke, Jose Teixeira, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 13, 2003
Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107
Thanh U Barbie, David A Barbie, David T MacLaughlin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 25, 2004
Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance
Elizabeth J Renaud, David T MacLaughlin, Esther Oliva, et al.
Fertility and Sterility
|
March 2, 2002
Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles
David B Seifer, David T MacLaughlin, Benjamin P Christian, et al.
Fertility and Sterility
|
January 18, 2005
Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment
Richard Fleming, Lyndal Harborne, David T MacLaughlin, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
February 1, 2002
New approaches for high-yield purification of Müllerian inhibiting substance improve its bioactivity
Hans K Lorenzo, Jose Teixeira, Nima Pahlavan, et al.
Gynecologic Oncology
|
November 9, 2010
Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines
Henry L Chang, Rafael Pieretti-Vanmarcke, Fotini Nicolaou, et al.
Developmental Biology
|
November 18, 2008
Cell migration and activated PI3K/AKT-directed elongation in the developing rat Müllerian duct
Akihiro Fujino, Nelson A Arango, Yong Zhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2002
Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo
Antonia E Stephen, Lisa A Pearsall, Benjamin P Christian, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Molecular and Cellular Endocrinology
|
December 6, 2003
MIS/AMH in the assessment of cryptorchidism and intersex conditions
Mary M Lee, Madhusmita Misra, Patricia K Donahoe, et al.
Molecular and Cellular Endocrinology
|
December 6, 2003
Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications
Patricia K Donahoe, Trent Clarke, Jose Teixeira, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 13, 2003
Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107
Thanh U Barbie, David A Barbie, David T MacLaughlin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 25, 2004
Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance
Elizabeth J Renaud, David T MacLaughlin, Esther Oliva, et al.
Fertility and Sterility
|
March 2, 2002
Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles
David B Seifer, David T MacLaughlin, Benjamin P Christian, et al.
Fertility and Sterility
|
January 18, 2005
Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment
Richard Fleming, Lyndal Harborne, David T MacLaughlin, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
February 1, 2002
New approaches for high-yield purification of Müllerian inhibiting substance improve its bioactivity
Hans K Lorenzo, Jose Teixeira, Nima Pahlavan, et al.
Gynecologic Oncology
|
November 9, 2010
Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines
Henry L Chang, Rafael Pieretti-Vanmarcke, Fotini Nicolaou, et al.
Developmental Biology
|
November 18, 2008
Cell migration and activated PI3K/AKT-directed elongation in the developing rat Müllerian duct
Akihiro Fujino, Nelson A Arango, Yong Zhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2002
Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo
Antonia E Stephen, Lisa A Pearsall, Benjamin P Christian, et al.
Page
of 5